Transperineal Injection of Hyaluronic Acid in Anterior Perirectal Fat to Decrease Rectal Toxicity From Radiation Delivered With Intensity Modulated Brachytherapy or EBRT for Prostate Cancer Patients

International Journal of Radiation Oncology Biology Physics

Volumn 69, Issue 1, 2007, Pages 95-102

  Prada, Pedro J ^a   Fernández, José ^a   Martinez, Alvaro A ^b   de la Rúa, Ángeles ^a   Gonzalez, Jose M ^a   Fernandez, Jose M ^a   Juan, German ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Brachytherapy; External radiation; Hyaluronic acid; Prostate cancer; Rectal protection and toxicity

Indexed keywords

DOSIMETERS; ONCOLOGY; ORGANIC ACIDS; THERMOLUMINESCENCE; TOXICITY;

BRACHYTHERAPY; EXTERNAL RADIATION; HYALURONIC ACID; PROSTATE CANCER; RECTAL PROTECTION;

RADIOTHERAPY;

HYALURONIC ACID;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CALCULATION; CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; RADIATION INJURY; RECTUM; RECTUM INJURY; THERMOLUMINESCENCE; ULTRASOUND; URETHRA;

ADIPOSE TISSUE, WHITE; AGED; BRACHYTHERAPY; HUMANS; HYALURONIC ACID; INJECTIONS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSTATE; PROSTATIC NEOPLASMS; RADIATION DOSAGE; RADIATION INJURIES; RADIATION PROTECTION; RADIATION-PROTECTIVE AGENTS; RADIOTHERAPY, INTENSITY-MODULATED; RECTUM;

EID: 34547828807     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.02.034     Document Type: Article

References (53)

1. Mettlin C.J., Murphy G.P., McDonald C.J., et al. The National Cancer data base report on increased use of brachytherapy for the treatment of patients with prostate carcinoma in USA. Cancer 86 (1999) 1877-1882
2. Lee R.W., Moughan J., Owen J., et al. The 1999 Patterns of Care Study of radiotherapy in localized prostatic carcinoma. A comprehensive survey of prostate brachytherapy in United States. Cancer 98 (2003) 1987-1994
3. Martinez A.A., Pataki I., Edmundson G., et al. Phase II prospective study of the use of conformal high-dose rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: A feasibility report. In. J Radiat Oncol Biol Phys 49 (2001) 61-69
4. Yoshioka Y., Nose T., Yoshida K., et al. High-dose rate interstitial brachytherapy as monotherapy for localized prostate cancer: Treatment description and preliminary results of a phase I/II clinical trial. Int J Radiat Oncol Biol Phys 48 (2000) 675-681
5. Grills I., Martinez A.A., Hollander M., et al. High dose rate brachytherapy as prostate cancer monotherapy treatment reduces toxicity compared to low dose rate palladium seeds. J Urol 171 (2004) 1098-1104
6. Martinez A., Gonzalez J., Spencer W., et al. Conformal high dose rate brachytherapy improves biochemical control and cause specific survival in patients with prostate cancer and poor prognostic factors. J Urology 169 (2003) 974-980
7. Galalae R.M., Kovács G., Schultze J., et al. Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose- rate brachytherapy for locally advanced prostate cancer. Int J Radiat Oncol Biol Phys 52 (2002) 81-90
8. Galalae R., Martinez A., and Mate T. Long-term outcome by risk factors using conformal high dose rate brachytherapy (HDR-BT) boost with or without neo-adjuvant androgen suppression for localized prostate cancer. Int J Radiat Oncol Biol Phys 58 (2004) 1048-1055
9. Martinez A.A., Gustafson G., Gonzalez J., et al. Dose escalation using conformal high dose rate brachytherapy improves outcome in unfavorable prostate cancer. Int J Radiat Oncol Biol Phys 53 (2002) 316-327
10. Demanes D.J., Rodriguez R.R., Schour L., et al. High-dose rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results. Int J Radiat Oncol Biol Phys 61 (2005) 1306-1316
11. Dattoli M., Wallner K., Sorace R., et al. Pd-I03 brachytherapy and external beam radiation therapy for clinically localized high risk prostatic carcinoma. Int J Radiat Oncol Biol Phys 35 (1996) 875-879
12. Martinez A., Gonzalez J., Spencer W., et al. Conformal high dose rate brachytherapy improves biochemical control and cause specific survival in patients with prostate cancer and poor prognostic factors. J Urol 169 (2003) 974-980
13. Ash D., Flynn A., Battermann J., et al. ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer. Radiother Oncol 57 (2000) 315-321
14. Battermann J.J., Boon T.A., and Moerland A. Results of permanent prostate brachytherapy, 13 years of experience at a single institution. Radiother Oncol 71 (2004) 23-28
15. 1o3Pd. Arch Esp Urol 55 (2002) 1217-1224
16. Prada P.J., De La Rua A., Hevia M., et al. High dose brachytherapy (real time) in patients with intermediate or high risk prostate cancer: Technical description and preliminary experience. Clin Transl Oncol 7 (2005) 389-397
17. Blasko J.C., Wallner K., Grimm P.D., et al. Prostate specific antigen based disease control following ultrasound guided iodine-125 implantation for state Tl/T2 prostatic carcinoma. J Urol 154 (1995) 1096-1099
18. Sylvester J.E., Blasko J.C., Grimm P.D., et al. Ten-year biochemical control relapse-free survival after external beam irradiation and brachytherapy for localized prostatic cancer: The Seattle experience. Int J Radiat Oncol Biol Phys 57 (2003) 952-964
19. Merrick G.S., Butler W.M., Wallner K.E., et al. Variability of prostate brachytherapy preimplant dosimetry: A multi-institutional analysis. Brachytherapy 5 (2005) 241-251
20. Zelefsky M.J., Wallner K.E., Ling C.C., et al. Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer. J Clin Oncol 17 (1999) 517-522
21. Wallner K., Roy J., and Harrison L. Tumor control and morbidity following transperineal I-125 implantation for stage Tl/T2 prostatic carcinoma. J Clin Oncol 14 (1996) 449-453
22. Gelblum D.Y., Potters L., Ashley R., et al. Urinary morbidity following ultrasound-guided transperineal prostate seed implantation. Int J Radiat Oncol Biol Phys 45 (1999) 59-67
23. Terk M.D., Stock R.G., and Stone N.N. Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate. J Urol 160 (1998) 1379-1382
24. Nag S., Scaperoth D.D., Badalament R., et al. Transperineal palladium 103 prostate brachytherapy: Analysis of morbidity and seed migration. Urology 45 (1995) 87-92
25. Vicini F.A., Kini V.R., Edmundson G., et al. A comprehensive review of prostate cancer brachytherapy: Defining an optimal technique. Int J Radiat Oncol Biol Phys 44 (1999) 483-491
26. 125I prostate implantation. Int J Radiat Oncol Biol Phys 28 (1994) 985-990
27. Daphna Y., and Gelblum L.P. Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys 48 (2000) 119-124
28. Merrick G.S., Butler W.M., Dorsey M.S., et al. Rectal dosimetric analysis following prostate brachytherapy. Int J Radiat Oncol Biol Phys 43 (1999) 1021-1027
29. Kenneth H., and Kent W. Clinical course of rectal bleeding following I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys 41 (1998) 263-265
30. Rubin P., and Cassarett G.W. Clinical radiation pathology (1968), W B Saunders, Philadelphia
31. Merrick G.S., Butler W.M., Dorsey A.T., et al. Rectal dosimetric analysis following prostate brachytherapy. Int J Radiat Oncol Biol Phys 43 (1999) 1021-1027
32. Wallner K., Roy J., and Harrison L. Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys 32 (1995) 465-471
33. Blasko J.C., Ragde H., and Grimm P.D. Transperineal ultrasound-guided implantation of the prostate: Morbidity and complications. Scand J Urol Nephrol Suppl 137 (1991) 113
34. Wallner K., Roy J., and Harrison L. Tumor control and morbidity following transperineal I-125 implantation for stage T1/T2 prostatic carcinoma. J Clin Oncol 14 (1996) 449-453
35. Edmundson G.K., Yan D., and Martinez A.A. Intra-operative optimization of needle placement and dwell times for conformal prostate brachytherapy. Int J Radiat Oncol Biol Phys 33 (1995) 1257-1263
36. Stromberg J., Martinez A., Gonzalez J., et al. Ultrasound-guided high dose rate conformal brachytherapy boost in prostate cancer: Treatment description and preliminary results of a phase I/II clinical trial. Int J Radiat Oncol Biol Phys 33 (1995) 161-171
37. Martinez A.A., Gonzalez J., Stromberg J., et al. Conformal prostate brachytherapy: Initial experience of a phase I/II clinical trial. Int J Radiat Oncol Biol Phys 33 (1995) 1019-1027
38. Teshima T., Hanks G.E., Hanlon A.L., et al. Rectal bleeding after conformal 3D treatment of prostate cancer: Time to occurrence, response to treatment and duration of morbidity. Int J Radiat Oncol Biol Phys 39 (1997) 77-83
39. George E. Intra-articular hyaluronan treatment for osteoarthritis. Ann Rheum Dis 57 (1998) 637-640
40. Wobig M., Bach G., Beks P., et al. The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: A comparison of Hyalin G-F20 and a lower molecular weight hyaluronan. Clin Ther 21 (1999) 1549-1562
41. Dougados M., Nguyen M., Listrat V., et al. High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: A 1 year placebo-controlled trial. Osteoarthritis Cart 1 (1993) 97-103
42. Puhl W., Bernau A., Greiling H., et al. Intraarticular sodium hyaluronate in osteoarthritis of the knee: A multicenter double-blind study. Osteoarthritis Cart 1 (1993) 233-241
43. Listrat V., Ayral X., Paternello F., et al. Arthroscopic evaluation of potential structure modifying activity of hyaluronan in osteoarthritis of the knee. Osteoarthritis Cart 5 (1997) 153-160
44. Altman R.D., and Moskowitz R. Intraarticular sodium hyaluronate in the treatment of patients with osteoarthritis of the knee: A randomized clinical trial. J Rheumatol 25 (1998) 2203-2213
45. Wachter S., Gerstner N., Dorner D., et al. The influence of a rectal balloon tube as internal immobilization device on variations of volumes and dose volume histograms during treatment course of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 52 (2002) 91-100
46. Teh B.S., Mai W.Y., Uhl B.M., et al. Intensity modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: Acute toxicity and dose volume analysis. Int J Radiat Oncol Biol Phys 49 (2001) 705-712
47. Nichol A.M., Jaffray D., Catton C., et al. A cohort study using cinematic magnetic resonance imaging of a bowel regime to reduce intrafraction prostate motion. Int J Radiat Oncol Biol Phys 60 (2004) s-429
48. Jaffray D.A., Siewerdsen J.H., Wong J.W., et al. Flat panel cone-beam computed tomography for image-guided radiation therapy. Int J Radiat Oncol Biol Phys 53 (2002) 1337-1349
49. Jaffray D.A., Drake D.G., Moreau M., et al. A radiographic and tomographic imaging system integrated into a medical linear accelerator for localization of bone and soft tissue targets. Int J Radiat Oncol Biol Phys 45 (1999) 1311-1323
50. Martinez A.A., Yan D., Lockman D., et al. Improvement in dose escalation using the process of adaptive radiotherapy combined with 3-D conformal or intensity modulated beams for prostate cancer. Int J Radiat Oncol Biol Phys 50 (2001) 1226-1243
51. Brabbins D., Martinez A.A., Yan D., et al. A dose escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: Analysis of chronic toxicity. Int J Radiat Oncol Biol Phys 61 (2005) 400-408
52. Vargas C., Martinez A.A., Kestin L., et al. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy. Int J Radiat Oncol Biol Phys 62 (2005) 1297-1308
53. Donner C.S. Pathophysiology and therapy of chronic radiation-induced injury to the colon. Dig Dis 16 (1998) 253-261